Uniphar (LON:UPR) Hits New 1-Year High - Here's What Happened

Key Points

• Uniphar plc's shares reached a new 52-week high of GBX 346.02 ($4.59) recently, indicating strong stock performance with a trading volume of 32,442 shares.
• Analysts have given mixed ratings, with Shore Capital maintaining a "buy" rating, while Deutsche Bank set a price target of GBX 375 ($4.97) with a "hold" recommendation.
• Uniphar has a market capitalization of £1.08 billion, a PE ratio of 24.06, and operates across various healthcare divisions, employing over 2,000 people.

Uniphar plc (LON:UPR - Get Free Report) reached a new 52-week high on Thursday . The stock traded as high as GBX 346.02 ($4.59) and last traded at GBX 346.02 ($4.59), with a volume of 32442 shares changing hands. The stock had previously closed at GBX 336 ($4.46).

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on UPR shares. Deutsche Bank Aktiengesellschaft reaffirmed a "hold" rating and issued a GBX 375 ($4.98) target price on shares of Uniphar in a research report on Wednesday. Shore Capital reaffirmed a "buy" rating on shares of Uniphar in a research report on Thursday, May 29th.

Uniphar Stock Up 1.8%

The firm has a 50 day moving average price of GBX 319.16 and a 200-day moving average price of GBX 257.39. The company has a current ratio of 0.90, a quick ratio of 0.60 and a debt-to-equity ratio of 119.48. The firm has a market cap of £1.08 billion, a PE ratio of 24.20 and a beta of 0.75.

About Uniphar

Headquartered in Dublin, Ireland Uniphar plc is a diversified healthcare services business servicing the requirements of more than 200 multinational pharmaceutical and medical technology manufacturers across three divisions – Commercial & Clinical, Product Access and Supply Chain & Retail. With a workforce of more than 2,000, the Group is active in Ireland, the UK and the Benelux.